Vasomotor symptoms in menopausal women. Other specified menopausal and perimenopausal disorders
Conditions
Interventions
Intervention 1: Intervention group: One session of wet cupping in the sacral area along with lifestyle measures to reduce menopausal symptoms. Intervention 2: Control group: given lifestyle measures
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 60 Years
Inclusion criteria
Inclusion criteria: The samples include postmenopausal women aged 45 to 60 years. At least one year has passed since their last menstruation; have hot flashes at least twice a day; have normal blood pressure (with or without me have the ability to cooperate and be fully satisfied with the treatment method.
Exclusion criteria
Exclusion criteria: Taking any hormonal medication to reduce menopausal symptoms in the past three months; Having the following diseases: carcinoid syndrome, systemic mast cell disease, pheochromocytoma, medullary thyroid carcinoma, pancreatic islet cell tumors, renal cell carcinoma, spinal cord injury. Taking medications: antithyroid, gabapentin SNRI, SSRI, clonidine, sulfonamides, methotrexate, triamterene, sulfasalazine, anticoagulants, raloxifene and tamoxifen. Using other traditional medications such as medications that cause hot flashes. Having a body mass index above 30; Having normal blood pressure (with or without medication); Not having diseases such as severe cardiovascular, metabolic, coagulation disorders, kidney, liver, thyroid or cancer diseases; No history of chemotherapy; Radiation therapy, lack of anemia or other conditions that prevent the use of cupping, addiction to drugs and alcohol.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Green's Questionnaire Score. Timepoint: Questionnaires are filled out at the beginning of the study and 7 and 28 days after the start of the intervention. Method of measurement: Green Menopausal Symptom Severity Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hot Flashes-Related Daily Interference Scale Questionnaire Score. Timepoint: The measurement points are at the beginning of the study and 7 and 28 days after the start of the intervention. Method of measurement: Hot Flashes-Related Daily Interference Scale Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham alavirad
Yazd University of Medical Sciences
Outcome results
None listed